Hysterectomy

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.

Concurrent hysterectomy decreased the 2-year risk of surgery for recurrent prolapse in the native tissue group (4.4% vs 7.8%), and recent/concurrent sling decreased recurrence risk in both native tiss

Effect: improvement; 4.4% with concurrent hysterectomy vs 7.8% without (native tissue group); CI: 95%CI with hysterectomy 3.9-4.9; without hysterectomy 7.3-8.